Diamant M, Van Gaal L, Stranks S, Northrup J, Cao D, Taylor K, et al
There was some evidence of asymmetry for MACE (Egger test, P = 0.059), suggesting a potential threat of publication bias
Baseline bloodwork CBC, CRP, ferritin, IL-6, cortisol AM, metabolic panel, thyroid function Cardiovascular assessment heart rate variability, orthostatic vitals if POTS is suspected Gut health markers stool testing, zonulin, calprotectin if GI symptoms are prominent Mitochondrial function proxies lactate, organic acids panel if PEM is a primary complaint From there, a typical protocol might be structured as: Phase 1 (Weeks 16): Immune and gut foundation Thymosin Alpha-1: 1.6 mg subcutaneous, twice weekly BPC-157: 250500 mcg daily, route determined by predominant symptom (oral for gut, injectable for systemic) Phase 2 (Weeks 412): Tissue repair and cardiovascular recovery TB-500: 2.02.5 mg subcutaneous, twice weekly Continue BPC-157 as indicated Phase 3 (Weeks 816): Maintenance and metabolic support Taper or pulse doses based on clinical response Add mitochondrial support if fatigue persists (see: Mitochondrial Peptides and Insulin Resistance) These are illustrative dosing ranges based on clinical research and published protocols
Whether youre starting a wellness reset or recovering from long weeks and late nights feel lighter, clearer, and balanced from within Supports Healthy Lymph Flow & Reduces Swelling: Backed by 13 detox botanicals like Echinacea, Dandelion, Burdock, and Cleavers, this blend promotes healthy lymph flow to reduce puffiness and water retention
Why Researchers Choose LiveWell Peptides for Semaglutide (GLP-1 Receptor Agonist) Research Peptide LiveWell Peptides is recognized as the best peptide company 2026 and a trusted peptide vendor for laboratories and independent researchers across the United States and internationally
